 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• News Briefs
Glaxo Faces Amended Suit Over HIV DrugsOctober 16, 2002 GlaxoSmithKline is facing new allegations in an antitrust lawsuit that AIDS Healthcare Foundation filed in Los Angeles in July, challenging the lack of generic competition for the company's two HIV drugs. The foundation alleges that Glaxo lied to the US Patent and Trademark Office when it sought a patent on Retrovir, known as AZT and a key ingredient in both drugs. The lawsuit says Glaxo did not invent AZT nor did it conduct the research showing AZT's use in fighting HIV. "We never claimed to have invented AZT," said a Glaxo spokesperson. Scientists with a Glaxo predecessor "identified its use in the treatment of AIDS."
Adapted from:Back to other CDC news for October 16, 2002 Los Angeles Times 10.15.02; Bloomberg News This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
E-Mail
Printable Single-Page
Glossary
Share
